Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Root Inc.'s Chief Administrative Officer, Jonathan Allison, sold 3,990 shares of Class A common stock on March 17, 2026, for $45.00 per share under a 10b5-1 trading arrangement, realizing $179,550. The transaction leaves Allison with 85,989 directly held shares. The sale coincides with ROOT trading close to a 52-week low and follows the company's f…
Hims & Hers Health COO Michael Chi executed a sale of 97,289 Class A shares on March 17, 2026, for $24.69 per share under an existing Rule 10b5-1 plan, netting about $2.4 million. The transaction leaves Chi with 407,282 shares. The sale coincides with significant corporate developments including a collaboration with Novo Nordisk, an analyst upgrade…
Opus Genetics Chief Operating Officer Joseph K. Schachle completed an automatic sale of 3,719 shares on March 16, 2026, yielding $19,525 to satisfy tax withholding tied to restricted stock unit vesting. The disposition occurs while Opus Genetics shares trade near a 52-week high amid recent clinical progress and a $25 million capital raise.
Esperion Therapeutics President and CEO Sheldon L. Koenig sold 25,578 shares on March 17, 2026, generating $69,546 at $2.719 per share. The sale, disclosed in an SEC filing, was made to satisfy tax obligations on vested restricted stock units. Esperion reported mixed fourth-quarter 2025 results and noted regulatory guideline recognition for its cho…
Esperion Therapeutics Chief Financial Officer Benjamin Halladay sold 6,424 shares on March 17, 2026, for $2.705 per share, a transaction totaling $17,376 intended to cover tax liabilities tied to vested restricted stock units. The sale was disclosed in an SEC Form 4 filed March 18, 2026; after the trade Halladay retained direct ownership of 713,602…
Control Empresarial de Capitales S.A. de C.V., which holds roughly ten percent of PBF Energy Inc. (NYSE: PBF), sold 650,700 Class A common shares on March 16 and 17, 2026, generating about $28.8 million. The transactions occurred while the stock was trading close to its 52-week high and following PBF's fourth-quarter 2025 earnings beat, which showe…
Privia Health Group, Inc. Executive Vice President and Chief Financial Officer David Mountcastle sold 6,391 shares on March 16, 2026, to meet tax withholding obligations related to vested performance stock units. The sale, recorded on an SEC Form 4, amounted to $141,305 at a per-share price of $22.11. The transaction took place while the stock trad…
Avalo Therapeutics Inc. (NASDAQ: AVTX) Chief Medical Officer Mittie Doyle sold 25,492 common shares on March 16, 2026, for $411,606 following the exercise of options to acquire an identical number of shares. The transactions coincide with recent analyst interest and a marked year-over-year share gain, while InvestingPro data flags the stock as trad…
Opus Genetics Chief Scientific & Development Officer Jayagopal Ashwath sold 3,719 shares on March 16, 2026, to satisfy tax withholding tied to vesting restricted stock units. The transaction, executed at a weighted average price of $5.1213 per share, left Ashwath with 516,775 directly held shares. The company also reported early, favorable safety d…
Guidewire Software Inc's Chief Executive Officer, Michael George Rosenbaum, sold 4,737 shares on March 17, 2026, generating $776,194 at $163.8579 per share. The sale, disclosed as a tax-covering move tied to the settlement of Restricted Stock Units, leaves Rosenbaum with 221,206 directly held shares. The transaction comes while the stock has fallen…
K. Christopher Farkas, Executive Vice President and Chief Financial Officer of Curtiss-Wright Corporation (NYSE: CW), sold 918 shares of common stock on March 17, 2026, to satisfy tax obligations related to the vesting of restricted stock units. The transactions followed the exercise of 2,183 RSU-derived shares on March 16, 2026. Curtiss-Wright als…
Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (EXCHANGE:RCG), purchased 1,134 common shares on March 17, 2026, at $3.27 per share, a price that matches the stock's 52-week high. The total value of the transactions was $3,708. Stahl's direct stake increased to 155,654 shares, and additional shares were allocated to accounts and…
Wesbanco director Kerry M Stemler disclosed purchases of WSBC common stock on March 18, 2026, totaling $30,800 across multiple transactions. The buys leave Stemler with a substantial direct and indirect holding. The disclosure comes as the bank reports mixed Q4 2025 results, announces a commercial expansion into South Florida with new hires, and it…
Steven J. McLaughlin, listed as a ten percent owner of Expensify, Inc. (NASDAQ: EXFY), indirectly purchased roughly $2.13 million of Class A common stock across five transactions between March 3 and March 11, 2026. The acquisitions took place while the share price hovered near a 52-week low of $0.74. Expensify's recent fourth-quarter 2025 results f…
Foxx Development Holdings Inc. (NASDAQ: FOXX) disclosed that Chief Executive Officer Greg Foley sold a total of 7,597 shares across two trades in March 2026, generating $30,436 in proceeds. The Form 4 filing also shows Foley retains 16,715 shares, including unvested restricted shares from a November 5, 2024 grant that vest quarterly. Separately, th…
Roger E. Susi, CEO, President and Chairman of IRADIMED CORP (NASDAQ:IRMD), sold 7,500 shares between March 16 and March 17, 2026, generating roughly $762,970 in proceeds under a Rule 10b5-1 plan adopted last November. The transactions occurred while IRMD traded near its 52-week high after a 100% one-year return, and InvestingPro analysis lists the …
Stephen J. Denelsky, a director of Harvard Bioscience Inc. (NASDAQ: HBIO), purchased 10,000 shares on March 17, 2026, at $4.87 per share for a total of $48,700. The transaction comes after a 10-for-1 reverse stock split on March 13, 2026, and leaves Denelsky with 21,000 shares, including 11,000 restricted stock units that vest on September 5, 2026.…
Kenneth M. Young, chief executive officer of Babcock & Wilcox Enterprises (NYSE: BW), purchased 7,000 shares on March 18, 2026, for $106,015 and earlier exercised options on March 16 to acquire 250,000 shares. The March activity also included a withholding of shares for tax obligations and a grant of 250,000 restricted stock units. The company repo…
Babcock & Wilcox Enterprises, Inc. CFO Cameron M. Frymyer bought 1,285 shares on March 18, 2026, and converted 225,000 restricted stock units into common shares the same day. The company also reported fourth-quarter 2025 results that slightly exceeded analyst expectations on both earnings per share and revenue.
Paul Howard Sutherland, a director at Gaia, Inc., purchased 5,486 shares of Class A common stock on March 16, 2026, paying $3.11 per share for a total of $17,061. The transaction leaves Sutherland with 302,943 shares directly owned. The buy occurred while Gaia shares traded near a 52-week low of $2.93 and after a six-month decline of 49%. Separatel…
HF Foods Group Inc. Chief Financial Officer Paul E. McGarry purchased 2,500 shares of company stock on March 18, 2026, paying $1.76 per share for a total of $4,400. The transaction comes as the stock hovers close to a 52-week low and after the company reported a 2.2% year-over-year increase in fourth-quarter 2025 net revenue to $1.23 billion.
HF Foods Group Inc. President and CEO Lin Xi bought 8,367 shares of the company’s common stock on March 18, 2026, spending $15,027 at $1.7961 per share. The transaction leaves Lin Xi with 424,171 directly held shares. The purchase occurred while HFFG shares trade close to a 52-week low, and follows the company’s Q4 2025 report showing a 2.2% increa…
Christine Chang, Chief Administrative Officer of HF Foods Group Inc (NASDAQ: HFFG), bought 4,000 shares of the company’s common stock on March 18, 2026, at $1.7399 per share, a transaction valued at $6,959. The purchase was disclosed in a Form 4 filed with the Securities and Exchange Commission. Following the trade, Chang’s direct holdings total 23…
Michael McNamara, Vicor Corp's General Manager of Manufacturing Operations, sold 7,174 shares on March 17, 2026, for about $1.36 million while exercising an equal number of options the same day. The combined transactions reflect an exercise-and-sell approach that produced net proceeds exceeding $1 million. Market valuation analysis from InvestingPr…
David J. Peuse, chief financial officer and treasurer of National Presto Industries Inc (NPK), sold 500 shares on March 17, 2026, for $140.155 per share, generating $70,077. The transaction, disclosed in an SEC Form 4, involved shares acquired through the company 401(k) plan between July 31, 2000 and March 31, 2020. After the sale, Peuse holds 1,66…
